Welcome to our dedicated page for Clover Leaf Capital news (Ticker: CLOEU), a resource for investors and traders seeking the latest updates and insights on Clover Leaf Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clover Leaf Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clover Leaf Capital's position in the market.
Clover Leaf Capital Corp. (NASDAQ: CLOEU) announced an extension for its business combination deadline from July 22, 2022, to October 22, 2022. This is the first of three possible three-month extensions as per its governing documents. The sponsor, Yntegra Capital Investments, will deposit $1,383,123 into the trust account by July 22, 2022, equating to $0.10 per public share. This extension allows the Company additional time to complete its initial business combination.
Clover Leaf Capital Corp. (NASDAQ: CLOEU) announces that starting September 9, 2021, holders of its initial public offering units can separately trade Class A common stock and rights. The IPO, completed on July 22, 2021, included 13,831,230 units. The separated Class A common stock will trade under the symbol CLOE, while rights will trade as CLOER. Units that are not separated will continue trading under CLOEU. This move facilitates greater trading flexibility for investors, although no fractional rights will be issued.
Clover Leaf Capital Corp. announced the closing of its initial public offering (IPO) of 13,831,230 units at $10.00 each. This includes 1,331,230 units sold from the underwriters’ over-allotment option. The units began trading on July 20, 2021, under the ticker symbol CLOEU.
Each unit contains one share of Class A common stock and a right to receive one-eighth of a share upon the Company's initial business combination. The shares are expected to trade under CLOE and the rights under CLOER.
Clover Leaf Capital Corp. (Nasdaq: CLOEU) has announced its initial public offering, pricing 12,500,000 units at $10.00 each. The units will trade on Nasdaq under CLOEU starting July 20, 2021. Each unit comprises one share of Class A common stock and one right to receive one-eighth of a share upon the completion of a business combination. The underwriters hold a 30-day option to purchase up to 1,875,000 additional units. The offering's closure is anticipated on July 22, 2021, subject to standard conditions.